170 324

Cited 0 times in

Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study

Authors
 Sang Myung Woo  ;  Min Kyeong Kim  ;  Boram Park  ;  Eun-Hae Cho  ;  Tae-Rim Lee  ;  Chang-Seok Ki  ;  Kyong-Ah Yoon  ;  Yun-Hee Kim  ;  Wonyoung Choi  ;  Do Yei Kim  ;  Jin-Hyeok Hwang  ;  Jae Hee Cho  ;  Sung-Sik Han  ;  Woo Jin Lee  ;  Sang-Jae Park  ;  Sun-Young Kong 
Citation
 CANCERS, Vol.13(21) : 5466, 2021-10 
Journal Title
CANCERS
Issue Date
2021-10
Keywords
circulating tumor DNA ; genomic instability ; genomic instability index ; instability score ; outcome prediction ; pancreatic cancer ; pancreatic ductal adenocarcinoma ; prognostic biomarker
Abstract
Genomic instability of circulating tumor DNA (ctDNA) as a prognostic biomarker has not been evaluated in pancreatic cancer. We investigated the role of the genomic instability index of ctDNA in pancreatic ductal adenocarcinoma (PDAC). We prospectively enrolled 315 patients newly diagnosed with resectable (n = 110), locally advanced (n = 78), and metastatic (n = 127) PDAC from March 2015 through January 2020. Low-depth whole-genome cell-free DNA sequencing identified genome-wide copy number alterations using instability score (I-score) to reflect genome-wide instability. Plasma cell-free and matched tumor tissue DNA from 15 patients with resectable pancreatic cancer was sequenced to assess the concordance of chromosomal copy number alteration profiles. Associations of I-score with clinical factors or survival were assessed. Seventy-six patients had high genomic instability with I-score > 7.3 in pre-treatment ctDNA; proportions of high I-score were 5.5%, 5.1%, and 52% in resectable, locally advanced, and metastatic stages, respectively. Correlation coefficients between Z-scores of plasma and tissue DNA at segment resolution were high (r2 = 0.82). Univariable analysis showed the association of I-score with progression-free survival in each stage. Multivariable analyses demonstrated that clinical stage-adjusted I-scores were significant factors for progression-free and overall survival. In these patients, ctDNA genomic I-scores provided prognostic information relevant to progression-free survival in each clinical stage.
Files in This Item:
T202105295.pdf Download
DOI
10.3390/cancers13215466
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Cho, Jae Hee(조재희) ORCID logo https://orcid.org/0000-0003-4174-0091
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/187217
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links